Viruses (Jul 2024)

HIV Persistence, Latency, and Cure Approaches: Where Are We Now?

  • Tessa C. Chou,
  • Nishad S. Maggirwar,
  • Matthew D. Marsden

DOI
https://doi.org/10.3390/v16071163
Journal volume & issue
Vol. 16, no. 7
p. 1163

Abstract

Read online

The latent reservoir remains a major roadblock to curing human immunodeficiency virus (HIV) infection. Currently available antiretroviral therapy (ART) can suppress active HIV replication, reduce viral loads to undetectable levels, and halt disease progression. However, antiretroviral drugs are unable to target cells that are latently infected with HIV, which can seed viral rebound if ART is stopped. Consequently, a major focus of the field is to study the latent viral reservoir and develop safe and effective methods to eliminate it. Here, we provide an overview of the major mechanisms governing the establishment and maintenance of HIV latency, the key challenges posed by latent reservoirs, small animal models utilized to study HIV latency, and contemporary cure approaches. We also discuss ongoing efforts to apply these approaches in combination, with the goal of achieving a safe, effective, and scalable cure for HIV that can be extended to the tens of millions of people with HIV worldwide.

Keywords